Dr. Pegram on the Evolving Treatment Landscape in HER2+ Breast Cancer - OncLive
7/29/2022 12:00:00 AM3 years 7 months ago
by Mark Pegram, MD, Stanford Women's Cancer Center
by Mark Pegram, MD, Stanford Women's Cancer Center
Mark Pegram, MD, discusses the evolving treatment landscape of HER2-positive breast cancer.
Mark Pegram, MD, Susy Yuan-Huey Hung professor of Oncology, medical director, Clinical and Translational Research Unit, associate dean, Clinical Research Quality, Stanford University School of Medici… [+780 chars]
full article...